These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 16715143

  • 1. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
    Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J.
    Oncogene; 2006 Oct 19; 25(49):6554-62. PubMed ID: 16715143
    [Abstract] [Full Text] [Related]

  • 2. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
    Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J.
    Oncogene; 2005 Dec 01; 24(54):8051-60. PubMed ID: 16103878
    [Abstract] [Full Text] [Related]

  • 3. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.
    Cancer Res; 2008 Jul 01; 68(13):5067-75. PubMed ID: 18593905
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J.
    Oncogene; 2007 Sep 27; 26(44):6456-68. PubMed ID: 17438526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
    Woo IS, Park MJ, Choi SW, Kim SJ, Lee MA, Kang JH, Hong YS, Lee KS.
    Oncol Rep; 2004 Mar 27; 11(3):617-22. PubMed ID: 14767512
    [Abstract] [Full Text] [Related]

  • 12. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A, Sasaki A, Nagasaki H, Shimada S, Otsubo T, Owaki S, Shimizu Y, Eishi Y, Kojima K, Nakajima Y, Kawano T, Yuasa Y, Akiyama Y.
    Gastroenterology; 2008 Aug 27; 135(2):580-90. PubMed ID: 18588891
    [Abstract] [Full Text] [Related]

  • 13. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y.
    Carcinogenesis; 2010 Dec 27; 31(12):2066-73. PubMed ID: 20924086
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, Shinomura Y.
    J Pathol; 2007 Oct 27; 213(2):131-9. PubMed ID: 17724792
    [Abstract] [Full Text] [Related]

  • 15. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
    Kim SK, Jang HR, Kim JH, Noh SM, Song KS, Kim MR, Kim SY, Yeom YI, Kim NS, Yoo HS, Kim YS.
    Biochem Biophys Res Commun; 2006 Oct 27; 349(3):1032-40. PubMed ID: 16959213
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
    Kim M, Jang HR, Kim JH, Noh SM, Song KS, Cho JS, Jeong HY, Norman JC, Caswell PT, Kang GH, Kim SY, Yoo HS, Kim YS.
    Carcinogenesis; 2008 Mar 27; 29(3):629-37. PubMed ID: 18283041
    [Abstract] [Full Text] [Related]

  • 18. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
    Haruki S, Imoto I, Kozaki K, Matsui T, Kawachi H, Komatsu S, Muramatsu T, Shimada Y, Kawano T, Inazawa J.
    Carcinogenesis; 2010 Jun 27; 31(6):1027-36. PubMed ID: 20200074
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.
    Kang JU, Koo SH, Kwon KC, Park JW.
    Int J Oncol; 2010 Aug 27; 37(2):327-35. PubMed ID: 20596660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.